USP24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.6618928455614E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.96520577588899E-12 |
Normal-vs-Stage2 |
3.61839447293733E-11 |
Normal-vs-Stage3 |
1.62725388719309E-12 |
Normal-vs-Stage4 |
2.1094237467878E-15 |
Stage1-vs-Stage2 |
9.845400E-01 |
Stage1-vs-Stage3 |
1.735670E-02 |
Stage1-vs-Stage4 |
1.992250E-02 |
Stage2-vs-Stage3 |
1.507790E-01 |
Stage2-vs-Stage4 |
1.216000E-01 |
Stage3-vs-Stage4 |
8.103200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.06341627012807E-14 |
Normal-vs-AfricanAmerican |
1.66078262253677E-12 |
Normal-vs-Asian |
2.533800E-02 |
Caucasian-vs-AfricanAmerican |
3.084200E-01 |
Caucasian-vs-Asian |
1.459040E-01 |
AfricanAmerican-vs-Asian |
7.320300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.64013247427874E-12 |
Normal-vs-Female |
2.65454325187875E-13 |
Male-vs-Female |
1.570440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.54549714640007E-11 |
Normal-vs-Age(41-60Yrs) |
1.7874590696465E-12 |
Normal-vs-Age(61-80Yrs) |
2.67563748934663E-14 |
Normal-vs-Age(81-100Yrs) |
5.07429653850977E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.293000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.507000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.547400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.550800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.389590E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.519000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.7016999999937E-05 |
Normal-vs-Grade 2 |
1.17184040249185E-12 |
Normal-vs-Grade 3 |
5.77315972805081E-15 |
Normal-vs-Grade 4 |
1.62492241884138E-12 |
Grade 1-vs-Grade 2 |
1.742010E-01 |
Grade 1-vs-Grade 3 |
1.206050E-02 |
Grade 1-vs-Grade 4 |
3.395500E-03 |
Grade 2-vs-Grade 3 |
6.638200E-03 |
Grade 2-vs-Grade 4 |
1.435000E-03 |
Grade 3-vs-Grade 4 |
1.633170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.12699849452724E-11 |
Normal-vs-ccB subtype |
1.11022302462516E-15 |
ccA subtype-vs-ccB subtype |
1.85441999999147E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.704525409707E-12 |
Normal-vs-N1 |
7.50900000000554E-05 |
N0-vs-N1 |
9.349600E-01 |
|
|